Xoft-a subsidiary of iCAD, Inc.
The Xoft® Electronic Brachytherapy System® (eBx®) is FDA-cleared for the treatment of cancer anywhere in the body; including early stage breast, gynecological and skin cancer. Its proprietary miniaturized x-ray source delivers precise, concentrated radiation to the tumor, minimizing risk of damage to healthy tissue in nearby areas of the body.